Pimavanserin and Aggression and Social Cognition.

NCT05895513 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Intermittent Explosive Disorder

Interventions

DRUG: Pimavanserin 34 mg
DRUG: Placebo

Sponsor

Ohio State University

Collaborators

[object Object]